Arylomycin Ring Synthesis via Palladium-Catalyzed Suzuki Coupling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The synthesis of arylomycin analogs and their ring portion is challenging due to difficulties in preparing the ring structure, which is essential for treating antibiotic-resistant bacterial infections, as existing methods result in low yields and potential racemization, affecting chiral purity.

Innovation Solution

A method involving a Suzuki coupling reaction using chloro(crotyl)(tri-tert-butylphosphine)palladium(II) as a catalyst to form the arylomycin ring, improving yields and chiral purity by avoiding racemization events, and subsequent amide bond formation to produce arylomycin analogs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If existing synthesis methods are used to prepare the arylomycin ring, then the synthesis can be performed, but the overall yield is low and racemization occurs reducing chiral purity

Engineering Contradiction:
Improvechiral purityVSAvoidoverall yield
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent changes the chemical parameters of the synthesis method by using a Suzuki coupling reaction with specific reagents (phenyl boronate compound, phenyl halide compound, and chloro(crotyl)(tri-tert-butylphosphine)palladium(II) catalyst) instead of existing methods. This parameter change resolves the contradiction by achieving both high overall yield (improving productivity) and avoiding racemization (maintaining manufacturing precision/chiral purity) through the specific reaction conditions and catalyst system employed

Inventive Principle:
Principle #35Parameter changes

2Productivity

If existing synthesis methods are used to prepare the arylomycin ring, then the synthesis can be performed, but the overall yield is low

Engineering Contradiction:
Improveoverall yieldVSAvoiddifficulty in preparing the ring structure
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent changes the synthesis parameters by employing a Suzuki coupling reaction with a specific palladium catalyst system (chloro(crotyl)(tri-tert-butylphosphine)palladium(II)). This approach simultaneously improves productivity through higher overall yield and ease of manufacture by providing a more straightforward synthetic route that avoids the difficulties associated with preparing the arylomycin ring structure using existing methods

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach achieves higher overall yields and improved chiral purity of the arylomycin ring, overcoming previous limitations in synthesizing arylomycin analogs, potentially providing effective treatments for antibiotic-resistant bacterial infections.

Implementation Method 1

reacting a phenyl boronate compound of formula m with a phenyl halide compound of formula e to form a compound of formula n

Methodology Applied
Scientific EffectSuzuki coupling reaction: Chemical Bonding

Implementation Method 2

treating the compound of formula n with chloro(crotyl)(tri-tert-butylphosphine)palladium(II), to make the compound of formula o

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 3

cyclizing compound v by forming an amide bond to make the compound o

Methodology Applied
Scientific EffectAmide bond formation: Chemical Bonding

Data Source

PatentUS11702452B2Process for making arylomycin ring analogs
Publication Date: 2023.07.18 GENENTECH INC
  • US11702452B2 patent drawing
  • US11702452B2 patent drawing
  • US11702452B2 patent drawing

AI summary

Methods for making an arylomycin ring of formula tor salts or solvates thereof, wherein R, R1, R2, R3, R4, R5, R6, R7, R8, R9, R5, R10 and Pg1 are as defined herein.